Reuters logo
BRIEF-Neurocrine Biosciences prices $450 mln convertible senior notes offering
April 26, 2017 / 11:06 PM / 5 months ago

BRIEF-Neurocrine Biosciences prices $450 mln convertible senior notes offering

April 26 (Reuters) - Neurocrine Biosciences Inc

* Prices $450.0 million convertible senior notes offering

* Priced offering of $450.0 million aggregate principal amount of 2.25% convertible senior notes due 2024 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below